1. Home
  2. UDMY vs CMPX Comparison

UDMY vs CMPX Comparison

Compare UDMY & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

N/A

Current Price

$4.62

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$5.20

Market Cap

926.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UDMY
CMPX
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
926.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
UDMY
CMPX
Price
$4.62
$5.20
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
$9.00
$14.43
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
05-04-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
105.36
N/A
EPS
0.03
N/A
Revenue
$789,844,000.00
N/A
Revenue This Year
$4.12
N/A
Revenue Next Year
$4.54
$830.89
P/E Ratio
$159.33
N/A
Revenue Growth
0.42
N/A
52 Week Low
$4.35
$1.33
52 Week High
$8.92
$6.88

Technical Indicators

Market Signals
Indicator
UDMY
CMPX
Relative Strength Index (RSI) 41.15 33.42
Support Level $4.35 $4.78
Resistance Level $5.38 $5.86
Average True Range (ATR) 0.24 0.32
MACD -0.02 -0.07
Stochastic Oscillator 8.33 1.47

Price Performance

Historical Comparison
UDMY
CMPX

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: